Fresenius Medical Care stock

FME · Xetra · EUR

Compare Fresenius Medical Care
€37.60Change from previous close: +2.40%Absolute change: +€0.88

Close · November 20, 2026

Price history

−5.10% over the period

1 year: from €39.62 (November 20, 2025) to €37.60 (November 20, 2026), −5.10%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026€37.60
October 30, 2026€40.40
September 30, 2026€39.57
August 31, 2026€39.45
July 31, 2026€44.45
June 30, 2026€39.60
May 29, 2026€37.19
April 30, 2026€38.61
March 31, 2026€38.57
February 27, 2026€39.45
January 30, 2026€37.91
December 30, 2025€40.76
November 28, 2025€41.25
November 20, 2025€39.62

At a glance

  • The company

    Provides dialysis treatment and related services for patients with renal disease, plus manufactures dialysis equipment and renal pharmaceuticals

  • Latest results

    Quarter to September 30, 2026 · EPS €1.11 (estimate €1.06)

TickerLandia's take on Fresenius Medical Care

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€34.57
52-wk high€45.90

−18.08% from the 52-week high

Analysts · 17 analysts

Average target€39.39+4.76% vs. price

Buy 4 · Hold 6 · Sell 7 · Hold

TickerLandia Fingerprint: Fresenius Medical Care

Compared with similar companies: very low growth and very low price.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Fresenius Medical Care is cheaper than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Fresenius Medical Care's P/E today is 11.2, below the median of its last 10 fiscal years (17.2; between 8.78 and 24.1 from 2016 to 2025). Fresenius Medical Care's P/E (trailing 12 months): 12.3, −30% against the median of a group of 10 similar companies (17.6).

P/E compared with its history

Compared with 10 similar companies

Fresenius Medical Care's metrics compared with similar companies
MetricFresenius Medical CarePosition in the groupBand
P/E (trailing 12 months)12.3Low
Forward P/E9.87Middle
Operating margin10.1%Middle
ROE7.8%Low
Debt/equity0.79Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Fresenius Medical Care. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€4.86B

Latest quarter · Q2 2026

Net income

€218.38M

Latest quarter · Q2 2026

Quarterly net margin

4.5%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€9.76B
P/E
12.3
EPS
€3.05
Volume
1.77M
Daily trading
€48.43M
Dividend yield
3.96%
Last ex-dividend on May 22, 2026

How Fresenius Medical Care is changing

All results
  • Revenue grew 1.9% a year on average over the last 5 years

  • Operating margin rose from 7.9% to 9.5%

Returns

Fresenius Medical Care returns with dividends

€1,000 invested in Fresenius Medical Care 5 years ago, on November 22, 2021, would be worth €781 today with dividends reinvested: −21.90% in total, −4.83% per year. On price alone it would be €675 (−32.47%).

PeriodFresenius Medical CareDAX€1,000 becomes
1 month−4.71%−1.98%€953
6 months−2.36%+0.26%€976
Year to date−7.75%+1.28%€922
1 year−1.30%+6.55%€987
3 years+16.13%+55.98%€1,161
5 years−21.90%+53.90%€781
10 years−35.68%+132.12%€643

Over the last 6 months it has done better than 19% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment

The chart in detail

Fresenius Medical Care: technical analysis

Fresenius Medical Care shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 59.6% below its all-time closing high (€93.00, January 31, 2018).

Trend
No clear trend
RSI (14 sessions)
40
Between 30 and 70
vs 200-session average
−5.42%

Support and resistance

Price areas where Fresenius Medical Care has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance€40.75+8.37%9 touches, last on September 28, 2026
  2. Resistance€39.04+3.83%5 touches, last on June 30, 2026
  3. Resistance€38.21+1.63%5 touches, last on November 3, 2026
  4. Last price€37.60
  5. Support€37.03−1.53%2 touches, last on March 23, 2026
  6. Support€35.68−5.11%3 touches, last on October 8, 2026

Volatility and risk

Over the last year it has moved little with the DAX.

Beta (1 year) vs DAX
0.15
Volatility (60 sessions, annualised)
33.2%
Largest fall in the last year
−18.15%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Fresenius Medical Care: seasonality

Average monthly price change over 30 years

+1.8%Jan+0.0%Feb+1.3%Mar+2.0%Apr−1.4%May+0.6%Jun+0.5%Jul−2.8%Aug−0.4%Sep−1.2%Oct+5.6%Nov+0.1%Dec

Over the last 30 years, the strongest month for Fresenius Medical Care has been November: +5.58% on average, positive in 19 years out of 30. The weakest has been August: −2.80% on average, positive in 9 years out of 30.

Show chart data
MonthAverageMedianPositive years
January+1.83%+1.21%16 of 30
February+0.04%+0.30%15 of 30
March+1.28%+0.91%19 of 30
April+1.98%+0.51%16 of 30
May−1.39%−1.13%12 of 30
June+0.65%+1.76%19 of 30
July+0.46%+1.12%18 of 30
August−2.80%−2.52%9 of 30
September−0.37%+1.19%19 of 30
October−1.23%−1.55%12 of 30
November+5.58%+3.14%19 of 30
December+0.13%+0.72%16 of 30

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Fresenius Medical Care and its competitors

Revenue of EUR 19.6 billion in the fiscal year ended 31 December 2025 comes from a business centred on dialysis for people with renal diseases in Germany, the United States and other countries. Dialysis treatment is delivered through a network of outpatient clinics, with laboratory and diagnostic services, patient support and home delivery of supplies, while US hospitals contract the group for care of end-stage renal disease and acute kidney failure patients.

Headquarters
Bad Homburg, Germany
Employees
106,291
Founded
1996
Chief executive
Helen Giza
Fresenius Medical Care and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Fresenius Medical CareFME$10.72B10.1%12.3−2.36%
MedicoverMCOV.B$3.82B7.4%38.3+19.86%
FreseniusFRE$31.8B9.9%18.4+27.91%
Spire Healthcare GroupSPI$1.3B7.6%—+12.90%
TerveystaloTTALO$830.61M8.9%13.0−27.00%
Universal Health ServicesUHS$10.34B10.9%7.51+9.20%

Same industry or related industries, similar size. Compare Fresenius Medical Care with its competitors · Full profile